BERKELEY, Calif, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering the next generation of technology ...
(RTTNews) - Profusa, Inc. (PFSA), a commercial-stage digital health company developing tissue-integrated biosensors, announced it has entered into a know-how agreement with Mayo Clinic to advance ...
(MENAFN- GlobeNewsWire - Nasdaq) Collaboration with Mayo Clinic aims to accelerate regulatory approval and commercialization of LumeeTM wearable continuous tissue oxygen monitoring product Seeking to ...